Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acutus Medical

Request full access

Provides patient-focused solutions for the electrophysiology community that help people live better lives

Carlsbad, United StatesFounded 2011Biotech & Life Sciences

About Acutus Medical

Acutus Medical is a pioneering company in the healthcare technology sector, specifically focusing on the treatment of complex cardiac arrhythmias. The company has developed a groundbreaking technology that allows physicians to visualize the electrical activity within a cardiac chamber in real time. This innovation is particularly significant for patients suffering from atrial arrhythmias, a condition where the heart beats irregularly. Traditional treatment options for these patients have often been slow to advance and have yielded less than satisfactory results.

Acutus Medical's flagship product is its unique imaging and mapping system, which includes a proprietary mapping algorithm known as SuperMap. This system is the first of its kind to offer three distinct mapping modes, enabling physicians to map any heart rhythm quickly and accurately. The SuperMap algorithm allows electrophysiologists—doctors specializing in the electrical functions of the heart—to map multi-circuit, stable rhythms in just three minutes. This rapid and consistent mapping capability is a significant improvement over existing technologies.

The primary clients for Acutus Medical are healthcare providers, particularly hospitals and specialized cardiac centers, and the electrophysiologists who work within these institutions. The company operates in the medical device market, which is a highly specialized and regulated sector.

Acutus Medical's business model revolves around the sale and distribution of its advanced mapping systems and related software. The company generates revenue through the direct sale of these systems, as well as through ongoing service and maintenance contracts. Additionally, Acutus may benefit from recurring revenue streams via software updates and potential licensing agreements.

In summary, Acutus Medical is revolutionizing the treatment of cardiac arrhythmias with its innovative mapping technology, providing significant benefits to both patients and healthcare providers.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Acutus Medical in the Carlsbad ecosystem

Live from Dealroom

The Acutus Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A3 investors entered at this stage

  • Advent Life Sciences
  • Advent Venture Partners
  • OrbiMed

Series B and later6 investors entered at this stage

  • GE Ventures
  • Xeraya Capital
  • Deerfield
  • Pura Vida Investments
  • Opaleye Management
  • 8VC
Team profiled 24 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States94.9%
🇧🇪 Belgium5.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Acutus Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acutus Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.